Diabetes Therapeutics Containing Glycoprotein Extracted from Chicken Coli

摘要

The present invention relates to a diabetic therapeutic agent comprising a glycoprotein component extracted from chicken janggi (Commelina communis L.) and a food for use in the diet of diabetic patients, the glycoprotein component extracted from the chicken janggi of the present invention is a sugar metabolism in liver tissue It has a direct effect on hepatic metabolism by restoring the activity and isoenzyme form of the enzyme glucose 6-phosphate dehydrogenase (G6PD).